用于接受透析治疗的终末期肾病的他汀类药物。 - Suppr

Suppr

超能文献

Statins for end-stage kidney disease treated with dialysis.

作者信息

Webster Angela, Palmer Suetonia, Ruospo Marinella, Strippoli Giovanni F M

出版信息

Nephrology (Carlton). 2015 Apr;20(4):302-3. doi: 10.1111/nep.12435.

DOI:10.1111/nep.12435

PMID:25810229

Abstract

摘要

相似文献

Statins for end-stage kidney disease treated with dialysis.

Nephrology (Carlton). 2015 Apr;20(4):302-3. doi: 10.1111/nep.12435.

Statins do not improve cardiovascular outcomes for dialysis patients.

Evid Based Med. 2014 Jun;19(3):89. doi: 10.1136/eb-2013-101606. Epub 2013 Dec 12.

Statins for chronic kidney disease not requiring dialysis.

Nephrology (Carlton). 2015 Apr;20(4):300-1. doi: 10.1111/nep.12434.

HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.

Sao Paulo Med J. 2015 Nov-Dec;133(6):541-2. doi: 10.1590/1516-3180.20151336T2.

Treatment with statins may be considered in ESRD patients for primary prevention of cardiovascular disease.

Kidney Int. 2009 Jun;75(12):1354-1355. doi: 10.1038/ki.2009.107.

Sunset for statins after AURORA?

N Engl J Med. 2009 Apr 2;360(14):1455-7. doi: 10.1056/NEJMe0901067. Epub 2009 Mar 30.

Should statins be prescribed for primary prevention of cardiovascular disease in patients with chronic kidney disease?

BMJ. 2009 Aug 20;339:b2949. doi: 10.1136/bmj.b2949.

Are HMG-CoA reductase inhibitors underutilized in dialysis patients?

Semin Dial. 2003 May-Jun;16(3):179-85. doi: 10.1046/j.1525-139x.2003.16036.x.

Statin use prolongs patient survival after renal transplantation.

J Am Soc Nephrol. 2008 Nov;19(11):2037-40. doi: 10.1681/ASN.2008090925. Epub 2008 Oct 8.

Statins in the prevention of cardiovascular events in patients with renal failure.

Cardiovasc Hematol Disord Drug Targets. 2007 Mar;7(1):7-13. doi: 10.2174/187152907780059119.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Statins for end-stage kidney disease treated with dialysis.

Nephrology (Carlton). 2015 Apr;20(4):302-3. doi: 10.1111/nep.12435.

Statins do not improve cardiovascular outcomes for dialysis patients.

Evid Based Med. 2014 Jun;19(3):89. doi: 10.1136/eb-2013-101606. Epub 2013 Dec 12.

Statins for chronic kidney disease not requiring dialysis.

Nephrology (Carlton). 2015 Apr;20(4):300-1. doi: 10.1111/nep.12434.

HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.

Sao Paulo Med J. 2015 Nov-Dec;133(6):541-2. doi: 10.1590/1516-3180.20151336T2.

Treatment with statins may be considered in ESRD patients for primary prevention of cardiovascular disease.

Kidney Int. 2009 Jun;75(12):1354-1355. doi: 10.1038/ki.2009.107.

Sunset for statins after AURORA?

N Engl J Med. 2009 Apr 2;360(14):1455-7. doi: 10.1056/NEJMe0901067. Epub 2009 Mar 30.

Should statins be prescribed for primary prevention of cardiovascular disease in patients with chronic kidney disease?

BMJ. 2009 Aug 20;339:b2949. doi: 10.1136/bmj.b2949.

Are HMG-CoA reductase inhibitors underutilized in dialysis patients?

Semin Dial. 2003 May-Jun;16(3):179-85. doi: 10.1046/j.1525-139x.2003.16036.x.

Statin use prolongs patient survival after renal transplantation.

J Am Soc Nephrol. 2008 Nov;19(11):2037-40. doi: 10.1681/ASN.2008090925. Epub 2008 Oct 8.

Statins in the prevention of cardiovascular events in patients with renal failure.

Cardiovasc Hematol Disord Drug Targets. 2007 Mar;7(1):7-13. doi: 10.2174/187152907780059119.